Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Yamada, Atsushi ^a   Cox, Mary A ^a   Gaffney, Kristin A ^b   Moreland, Amber ^b   Boland, C Richard ^a   Goel, Ajay ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; MICRORNA 125B; MICRORNA 16; MICRORNA 21; MICRORNA 29A; TUMOR MARKER; MICRORNA;

ARTICLE; BLOOD SAMPLING; CLINICAL LABORATORY; COLONOSCOPY; COLORECTAL TUMOR; CONTROLLED STUDY; DILUTION; GENE EXPRESSION; HEMOLYSIS; HUMAN; INTESTINE PREPARATION; LABORATORY TEST; MAJOR CLINICAL STUDY; RNA ANALYSIS; RNA EXTRACTION; RNA STABILITY; SPECTROPHOTOMETRY; BLOOD; CASE CONTROL STUDY; EARLY CANCER DIAGNOSIS; PROCEDURES; SENSITIVITY AND SPECIFICITY; STANDARDS;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; MICRORNAS; SENSITIVITY AND SPECIFICITY;

EID: 84913534500     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112481     Document Type: Article

References (27)

1. Schwarzenbach H, Nishida N, Calin GA, Pantel K (2014) Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 11: 145-156.
2. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
3. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261.
4. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
5. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
6. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A (2011) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833-840.
7. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, et al. (2011)Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108: 5003-5008.
8. Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39: 7223-7233.
9. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT (2011) MicroRNAs are transported in plasma and delivered to recipient cells by highdensity lipoproteins. Nat Cell Biol 13: 423-433.
10. Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110: 13-21.
11. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3: e3694.
12. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH (2009) Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10: 42-46.
13. Moldovan L, Batte KE, Trgovcich J, Wisler J, Marsh CB, et al. (2014) Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med 18: 371-390.
14. Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, et al. (2012) Comparing theMicroRNA spectrum between serum and plasma. PLoS One 7: e41561.
15. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, et al. (2012) Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer 130: 1378-1386.
16. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, et al. (2011) Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 6: e24145.
17. Duttagupta R, Jiang R, Gollub J, Getts RC, Jones KW (2011) Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 6: e20769.
18. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, et al. (2012) Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 5: 492-497.
19. Kirschner MB, Edelman JJ, Kao SC, Vallely MP, van Zandwijk N, et al. (2013) The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Front Genet 4: 94.
20. Koberle V, Pleli T, Schmithals C, Augusto Alonso E, Haupenthal J, et al. (2013) Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers. PLoS One 8: e75184.
21. Fortunato O, Boeri M, Verri C, Conte D, Mensah M, et al. (2014) Assessment of circulating microRNAs in plasma of lung cancer patients. Molecules 19: 3038-3054.
22. Baggish AL, Hale A, Weiner RB, Lewis GD, Systrom D, et al. (2011) Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol 589: 3983-3994.
23. Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, et al. (2012) Plasma miR-21: a potential diagnostic marker of colorectal cancer. Ann Surg 256: 544-551.
24. Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, et al. (2013) Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 105: 849-859.
25. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126.
26. Giraldez MD, Lozano JJ, Ramirez G, Hijona E, Bujanda L, et al. (2013) Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clin Gastroenterol Hepatol 11: 681-688 e683.
27. Cripps CM (1968) Rapid method for the estimation of plasma haemoglobin levels. J Clin Pathol 21: 110-112.